RU2247389C2 - Способ идентификации индивидуума с риском сосудистого и ракового заболевания - Google Patents

Способ идентификации индивидуума с риском сосудистого и ракового заболевания Download PDF

Info

Publication number
RU2247389C2
RU2247389C2 RU2002107982/15A RU2002107982A RU2247389C2 RU 2247389 C2 RU2247389 C2 RU 2247389C2 RU 2002107982/15 A RU2002107982/15 A RU 2002107982/15A RU 2002107982 A RU2002107982 A RU 2002107982A RU 2247389 C2 RU2247389 C2 RU 2247389C2
Authority
RU
Russia
Prior art keywords
concentration
homocysteine
serum
pgi
individual
Prior art date
Application number
RU2002107982/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2002107982A (ru
Inventor
Пентти СИППОНЕН (FI)
Пентти Сиппонен
Матти ХЯРКЕНЕН (FI)
Матти Хяркенен
Осмо СУОВАНИЕМИ (FI)
Осмо Суованиеми
Original Assignee
Биохит Ойй
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Биохит Ойй filed Critical Биохит Ойй
Publication of RU2002107982A publication Critical patent/RU2002107982A/ru
Application granted granted Critical
Publication of RU2247389C2 publication Critical patent/RU2247389C2/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • G01N33/6815—Assays for specific amino acids containing sulfur, e.g. cysteine, cystine, methionine, homocysteine

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
RU2002107982/15A 1999-08-31 2000-08-30 Способ идентификации индивидуума с риском сосудистого и ракового заболевания RU2247389C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI991836A FI107808B (fi) 1999-08-31 1999-08-31 Menetelmä verisuoni- sekä syöpäsairaudelle riskialttiin yksilön identifioimiseksi
FI19991836 1999-08-31

Publications (2)

Publication Number Publication Date
RU2002107982A RU2002107982A (ru) 2003-11-10
RU2247389C2 true RU2247389C2 (ru) 2005-02-27

Family

ID=8555217

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002107982/15A RU2247389C2 (ru) 1999-08-31 2000-08-30 Способ идентификации индивидуума с риском сосудистого и ракового заболевания

Country Status (7)

Country Link
EP (1) EP1210452A1 (ja)
JP (1) JP2003508059A (ja)
CN (1) CN1158389C (ja)
AU (1) AU6845600A (ja)
FI (1) FI107808B (ja)
RU (1) RU2247389C2 (ja)
WO (1) WO2001016356A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2453001C1 (ru) * 2010-10-18 2012-06-10 Государственное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" Способ коррекции гипергомоцистеин индуцированного дефицита оксида азота l-норвалином в эксперименте

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114924016B (zh) * 2022-04-28 2024-03-08 中国医学科学院北京协和医院 同时检测硫酸化及未硫酸化胃泌素g17的方法及其检测试剂盒

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI97304C (fi) * 1994-11-16 1996-11-25 Locus Genex Oy Menetelmä mahasyövän riskin seulonnaksi

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Болезни органов кровообращения. Лечение опухолевых заболеваний. Справочник практического врача. Изд-во "БАЯН", 1994, с.34-52, 60-95. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2453001C1 (ru) * 2010-10-18 2012-06-10 Государственное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" Способ коррекции гипергомоцистеин индуцированного дефицита оксида азота l-норвалином в эксперименте

Also Published As

Publication number Publication date
CN1158389C (zh) 2004-07-21
FI107808B (fi) 2001-10-15
AU6845600A (en) 2001-03-26
CN1371427A (zh) 2002-09-25
JP2003508059A (ja) 2003-03-04
FI19991836A (fi) 2001-02-28
WO2001016356A1 (en) 2001-03-08
EP1210452A1 (en) 2002-06-05

Similar Documents

Publication Publication Date Title
Ueland et al. Total homocysteine in plasma or serum: methods and clinical applications
JP2579434B2 (ja) コバラミンおよび葉酸の欠乏を検出および区別する方法
Still et al. ACP Broadsheet No 152: March 1998. Clinical implications of plasma homocysteine measurement in cardiovascular disease.
Nexø et al. How to diagnose cobalamin deficiency
KR100394940B1 (ko) 간 질환 진단을 위한 혈중 아사이알로당단백질양의측정방법 및 측정용 킷트
Zighetti et al. Determination of total homocysteine in plasma: comparison of the Abbott IMx immunoassay with high performance liquid chromatography
Sheabar et al. Quantitative analysis of aflatoxin-albumin adducts
EP2894477A1 (en) Method for determining breast cancer
DE60217665T2 (de) Verfahren zur Bestimmung der Aktivität von Thymidinkinase-1 und dessen Verwendung
Wang Concentration of arsenic, selenium, zinc, iron and copper in the urine of blackfoot disease patients at different clinical stages
Harrington Methods for assessment of vitamin B12
ES2698518T3 (es) Medición de ensayo precisa de analitos hapténicos hidrófobos
RU2247389C2 (ru) Способ идентификации индивидуума с риском сосудистого и ракового заболевания
RU2224258C2 (ru) Способ идентификации индивидуума, у которого существует риск необратимых неврологических повреждений, включающий в себя этапы количественного определения концентрации пепсиногена i (pgi) и витамина в12
JP2003508059A5 (ja)
Zappacosta et al. Comparing different methods for homocysteine determination
Finglas et al. Validity of dual-label stable isotopic protocols and urinary excretion ratios to determine folate bioavailability from food
Urdal et al. Measurement of magnesium in mononuclear blood cells.
JP3564668B2 (ja) 体液中のアポリポタンパク質ｄレベルの測定による前立腺ガンのスクリーニング方法
Mourvaki et al. Performance comparison of three assay methods used in fasting and postmethionine load plasma homocysteine determinations from patients with vascular disease
Cao et al. Effects of Biotin Supplements Ingestion on Beckman Biotinylated Immunoassays
Serin et al. Alkaline phosphatase interference in immuno-enzymatic assays.
JP2002523749A (ja) 心血管疾患のためのアッセイ方法
Guerrero Irigoyen et al. Simultaneous determination of CXCL7 chemokine and MMP3 metalloproteinase as biomarkers for rheumatoid arthritis
Sarma et al. Direct microtitre plate enzyme immunoassay of folic acid without heat denaturation of serum